FDA Section 5 \u2022 cited verbatim

Meropenem - Warnings and Precautions

The following warnings and precautions are taken directly from the US FDA-approved drug label for Meropenem. This is the same information dispensing pharmacists read.

5 WARNINGS AND PRECAUTIONS 7.

Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving β-lactams.

Severe cutaneous adverse reactions have been reported in patients receiving Meropenem for injection (I.V.).

Seizures and other adverse CNS experiences have been reported during treatment. ( Error! Hyperlink reference not valid. ) 10.

Co-administration of Meropenem for injection (I.V.) with valproic acid or divalproex sodium reduces the serum concentration of valproic acid potentially increasing the risk of breakthrough seizures. ( 5.4 , 7.2 ) 11.

Clostridium difficile- associated diarrhea (ranging from mild diarrhea to fatal colitis) has been reported.

Evaluate if diarrhea occurs.

In patients with renal dysfunction, thrombocytopenia has been observed.

5.1 Hypersensitivity Reactions Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving therapy with β-lactams.

These reactions are more likely to occur in individuals with a history of sensitivity to multiple allergens.

There have been reports of individuals with a history of penicillin hypersensitivity who have experienced severe hypersensitivity reactions when treated with another β-lactam.

Before initiating therapy with Meropenem for injection (I.V.), it is important to inquire about previous hypersensitivity reactions to penicillins, cephalosporins, other β-lactams, and other allergens.

If an allergic reaction to Meropenem for injection (I.V.) occurs, discontinue the drug immediately.

5.2 Severe Cutaneous Adverse Reactions Severe cutaneous adverse reactions (SCAR) such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), erythema multiforme (EM) and acute generalized exanthematous pustulosis (AGEP) have been reported in patients receiving Meropenem for injection (I.V.) [ see AdverseReactions ].

If signs and symptoms suggestive of these reactions appear, meropenem should be withdrawn immediately and an alternative treatment should be considered.

5.3 Seizure Potential Seizures and other adverse CNS experiences have been reported during treatment with Meropenem for injection (I.V.).

These experiences have occurred most commonly in patients with CNS disorders (e.g., brain lesions or history of seizures) or with bacterial meningitis and/or compromised renal function [ see Adverse Reactionsand Drug Interactions ].

During clinical investigations, 2904 immunocompetent adult patients were treated for non-CNS infections with the overall seizure rate being 0.7% (based on 20 patients with this adverse event).

All meropenem-treated patients with seizures had pre-existing contributing factors.

Among these are included prior history of seizures or CNS abnormality and concomitant medications with seizure potential.

Dosage adjustment is recommended in patients with advanced age and/or adult patients with creatinine clearance of 50 mL/min or less [ see Dosage and Administration ].

Close adherence to the recommended dosage regimens is urged, especially in patients with known factors that predispose to convulsive activity.

Continue anti-convulsant therapy in patients with known seizure disorders.

If focal tremors, myoclonus, or seizures occur, evaluate neurologically, placed on anti-convulsant therapy if not already instituted, and re-examine the dosage of Meropenem for injection (I.V.) to determine whether it should be decreased or discontinued.

5.4 Risk of Breakthrough Seizures Due to Drug Interaction with Valproic Acid The concomitant use of meropenem and valproic acid or divalproex sodium is generally not recommended.

Applies to YOU?

Some warnings apply only to specific age groups, health conditions, or other medicines. Ask GoDavaii AI to filter which of these 45+ warnings apply to your profile.

Ask Health AI \u2192